PASW

Ping An Biomedical Co., Ltd. (PASW) Business Model Analysis (2026)

Invetso Score: 5.2/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Value Proposition Revenue Model

Score: 5.4 (Moderate)

Revenue mix: Asset turnover of 0.50 implies a capital-intensive revenue model that converts assets into sales at a moderate rate.

Cash conversion: Income quality near 0.50 indicates roughly half of accounting earnings convert to cash, limiting revenue-to-cash predictability.

Peer structure: Relative to lighter-asset peers, the model appears less scalable because growth requires more balance-sheet support.

Cost Structure

Score:

Capital intensity: Capex-to-revenue and capex-to-OCF at zero in the dataset provide no evidence of current reinvestment burden, but asset intensity remains visible.

Operating leverage: Moderate asset turnover suggests fixed asset absorption is present, which can support margins at scale but also constrains flexibility.

Peer comparison: Compared with asset-light peers, the cost structure appears less efficient because more capital is tied to each unit of revenue.

Scalability Operating Leverage

Score:

Scale economics: Asset turnover below 1.0 indicates revenue can grow, but scaling likely requires proportional asset expansion.

Margin leverage: The model can benefit from utilization gains, yet the current structure does not show strong operating leverage versus peers.

Structural constraint: Low visible reinvestment metrics limit confidence in near-term scalability and margin expansion.

Customer Structure Concentration

Score:

Customer visibility: No customer concentration data is provided, so structural concentration risk cannot be confirmed from the supplied metrics.

Business mix: The available metrics suggest a broad operating base rather than a highly recurring, contract-led customer structure.

Peer relativity: Versus subscription or diversified B2B peers, predictability appears more limited because cash conversion is only moderate.

Revenue Quality Predictability

Score:

Cash quality: Income quality around 0.50 indicates weaker earnings-to-cash conversion, reducing revenue quality and forecastability.

Stability: The absence of strong cash-conversion evidence suggests revenue may be more sensitive to working-capital and asset utilization swings.

Peer comparison: Compared with peers that convert a larger share of earnings into cash, this model appears less predictable.

Overall Score

Score:

PASW has a moderate business model with asset-based revenue generation and acceptable scale potential, but cash conversion and asset intensity limit predictability.

Score Driver: Asset Turnover Near 0.50 Anchors The Model As Moderately Scalable, While Income Quality Near 0.50 Materially Weakens Revenue Quality And Resilience.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Ping An Biomedical Co., Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →